Welcome to LookChem.com Sign In|Join Free

CAS

  • or

145631-03-4

Post Buying Request

145631-03-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Carbamic acid,[(1S,2S,4R)-5-[[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]amino]-2-hydroxy-5-oxo-1,4-bis(phenylmethyl)pentyl]-,(3S)-tetrahydro-3-furanyl ester (9CI)

    Cas No: 145631-03-4

  • No Data

  • No Data

  • No Data

  • Henan Tianfu Chemical Co., Ltd.
  • Contact Supplier

145631-03-4 Usage

Description

(3S)-tetrahydrofuran-3-yl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is a complex organic molecule characterized by a tetrahydrofuran ring and multiple functional groups, including a carbamate, dibenzyl, and several hydroxy and amino groups. (3S)-tetrahydrofuran-3-yl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate exhibits stereochemistry with specific configurations at the tetrahydrofuran, dibenzyl, and hydroxy groups, which may contribute to its potential applications in medicinal chemistry.

Uses

Used in Pharmaceutical Development:
(3S)-tetrahydrofuran-3-yl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is used as a potential candidate in the pharmaceutical industry for the development of new drugs. The presence of hydroxy and amino groups, which are common in drug molecules, suggests that this compound could be utilized in the synthesis of novel pharmaceutical compounds with potential therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (3S)-tetrahydrofuran-3-yl [(1S,2S,4R)-1,4-dibenzyl-2-hydroxy-5-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino-5-oxopentyl]carbamate is used as a subject of study to explore its chemical properties, reactivity, and potential interactions with biological targets. Understanding these aspects can lead to the design of more effective drugs targeting specific diseases or conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 145631-03-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,6,3 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 145631-03:
(8*1)+(7*4)+(6*5)+(5*6)+(4*3)+(3*1)+(2*0)+(1*3)=114
114 % 10 = 4
So 145631-03-4 is a valid CAS Registry Number.

145631-03-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name [(3S)-oxolan-3-yl] N-[(2S,3S,5R)-5-benzyl-3-hydroxy-6-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-6-oxo-1-phenylhexan-2-yl]carbamate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:145631-03-4 SDS

145631-03-4Downstream Products

145631-03-4Relevant articles and documents

HIV protease inhibitors useful for the treatment of aids

-

, (2008/06/13)

Compounds of the form,ψ ψ A-G-Jψ ψ wherein A is an amine protecting group or urethane, G a dipeptide isostere and J a small terminal group are described. They are distinguished by tetrahydrofuryl or tetrahydropyranyl substituents, and the like. These compounds are useful in the inhibition of HIV protease, the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ingredients, whether or not in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.ψ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 145631-03-4